E. Schmitt et al. / Tetrahedron 66 (2010) 6349e6357
6355
21
were dried and freshly distilled under argon according to stan-
C
16H24N2O ([Mþ]) 260.1883. Found: 260.1883; [
a
]
ꢀ134.3 (c
D
dard procedures. Anhydrides 1ge1j were prepared from the
corresponding diacids by dehydration with trifluoroactic anhy-
dride. All other reagents were obtained from commercial sources
and used as received. Column chromatography was done on silica
1.34, CHCl3).
4.2.4. 2-{[(9-epi-Aminoquinidin-9-yl)imino]methyl}-4-methylphenol
(9). Yellow solid; mp 83e85 ꢁC; 1H NMR (CDCl3, 300 MHz)
gel 60 (40e63
m
m) from Merck as stationary phase. TLC was
d 0.99e1.06 (m, 1H), 1.16e1.28 (m, 1H), 1.49e1.58 (m, 2H),
performed using precoated aluminum plates (Merck silica gel 60
F254). Detection was done either using UV light (254 nm) or
KMnO4 stain. NMR spectra were recorded on a Varian Inova 400
(400 MHz) or Mercury 300 (300 MHz) instrument. Chemical
1.60e1.67 (m, 1H), 2.24 (s, 3H), 2.26e1.34 (m, 1H), 2.82e3.10 (m,
4H), 3.44 (q, J¼9.4 Hz, 1H), 4.01 (s, 3H), 4.92 (d, J¼9.7 Hz, 1H),
5.05 (dt, J¼5.7, 1.5 Hz, 1H), 5.08e5.12 (m, 1H), 5.82e5.95 (m, 1H),
6.82 (d, J¼8.2 Hz, 1H), 7.00e7.10 (m, 2H), 7.40 (dd, J¼9.2, 2.7 Hz,
1H), 7.49 (d, J¼4.5 Hz, 1H), 7.57 (d, J¼2.5 Hz, 1H), 8.03 (d,
J¼9.2 Hz, 1H), 8.33 (s, 1H), 8.76 (d, J¼4.5 Hz, 1H), 13.07 (br s, 1H);
shifts are given in parts per million relative to TMS (
d
¼0 ppm) or
solvent residual peaks as internal standards. Mass spectra were
recorded on a Finnigan SSQ 7000 system (EI, 70 eV). Elemental
analyses were measured on an Elementar Vario EL instrument. IR
spectra were recorded on a PerkinElmer Spectrum 100 FT-IR
13C NMR (CDCl3, 75 MHz)
d
20.3, 24.9, 26.5, 27.8, 39.5, 47.6, 49.6,
55.6, 61.0, 70.5, 101.6, 114.6, 116.6, 118.5, 121.2, 121.8, 127.7, 131.8,
132.1, 133.2, 140.5, 144.5, 145.0, 147.7, 157.9, 158.7, 165.5; IR (KBr)
n
spectrometer. Optical rotations were measured on
a
Per-
2934, 2108, 1626, 1493, 1221, 1029, 914, 821, 714, 666 cmꢀ1
;
kineElmer Model P241 instrument using a light frequency of
589 nm. Concentration c is listed in g/100 mL. Melting points
were determined on a Büchi B-450 apparatus in open capillaries
and are uncorrected.
HRMS calcd for C28H31N3O2 ([Mþ]) 441.2411. Found: 441.2424;
21
[
a
]
þ137.7 (c 1.10, CHCl3).
D
4.2.5. N-[(1S,2S)-2-(Piperidin-1-yl)cyclohexyl]3,5-bis(trifluoro-
methyl)benzenesulfonamide (10a). White solid; mp 110e111 ꢁC; 1H
4.2. Preparation of catalysts
NMR (CDCl3, 400 MHz) d 1.00e1.27 (m, 4H), 1.28e1.56 (m, 6H),
1.62e1.70 (m, 1H), 1.73e1.86 (m, 2H), 2.10e2.36 (m, 6H), 2.75e2.86
Aminoalcohols 5ae5e,11 5f,23 7,11 and thioureas 11c and 11d16
were prepared according to the literature procedures. Com-
pounds 6a and 6b were obtained by alkylations of the commercial
available (S,S)-(ꢀ)-2-amino-1,2-diphenylethanol. All enantiopure
cyclohexane-based diamine derivatives, imines 8,14a sulfonamides
10,10a thioureas 11, and squareamide 1219 were prepared from the
corresponding enantiopure 1,2-cyclohexane diamine.14 Imine 924
was obtained from 9-epi-aminoquinidine following literature
procedures.
(m, 1H), 6.20 (br s, 1H), 8.05 (s, 1H), 8.34 (s, 2H); 13C NMR (CDCl3,
100 MHz)
d 22.9, 24.2, 24.5, 25.3, 26.5, 32.6, 49.2, 53.9, 67.3, 122.5
(q, J¼272.8 Hz), 125.9, 127.3, 132.7 (q, J¼34.3 Hz), 143.3; IR (KBr)
n
3149, 2933, 1740, 1452, 1354, 1278, 1136, 964, 900, 843, 680 cmꢀ1
;
MS (EI, 70 eV) m/z 459 ([MþH]þ, 9%), 439 (9%), 213 (18%), 181
(100%), 164 (13%), 96 (11%), 84 (13). Anal. Calcd for C19H24F6N2O22S2:
C, 49.78; H, 5.25; N, 6.11. Found: C, 49.66; H, 5.23; N, 6.06; [a]
D
þ60.1 (c 1.39, CHCl3).
4.2.6. N-[(1R,2R)-2-(Dimethylamino)cyclohexyl]3,5-bis(tri-
4.2.1. (1S,2S)-trans-2-(Piperidin-10-yl)-cyclopentanol
solid; mp 49e51 ꢁC; 1H NMR (CDCl3, 400 MHz)
1.38e1.49 (m, 3H),
1.49e1.72 (m, 7H), 1.78e1.95 (m, 2H), 2.41e2.54 (m, 5H), 2.84 (br s,
1H), 4.07e4.14 (m, 1H); 13C NMR (CDCl3, 100 MHz)
21.8, 24.6, 26.1,
3140, 2930, 2083, 1448, 1332,
(7). White
fluoromethyl)benzenesulfonamide (10b). White solid; mp 80e81 ꢁC;
d
1H NMR (CDCl3, 400 MHz)
d 0.95e1.24 (m, 4H), 1.60e1.67 (m, 1H),
1.71e1.80 (m, 2H), 1.98 (s, 6H), 2.13e2.21 (m, 1H), 2.21e2.28 (m,
d
1H), 2.69e2.78 (m, 1H), 8.03 (s, 1H), 8.32 (s, 2H); 13C NMR (CDCl3,
27.1, 34.4, 52.4, 74.9, 75.5; IR (KBr)
n
100 MHz)
d
21.2, 24.2, 25.0, 39.7, 54.5, 66.3, 122.5 (q, J¼272.9 Hz),
1255, 1175, 1108, 1038, 987, 903, 872, 805, 739, 661 cmꢀ1; MS (EI,
70 eV) m/z 169 ([Mþ], 24%), 124 (100%), 110 (44%), 98 (22%). Anal.
Calcd for C10H19NO: C, 70.96; H, 11.31; N, 8.28. Found: C, 71.32; H,
125.8, 127.5, 132.6 (q, J¼34.3 Hz), 143.5; IR (KBr)
n 3095, 2945, 1739,
1454, 1353, 1274, 1109, 970, 900, 844, 729, 680 cmꢀ1; MS (EI, 70 eV)
m/z 418 ([M], 9%), 399 (16%), 213 (40%), 141 (100%), 124 (55%), 96
(52%), 84 (21%), 70 (22%). Anal. Calcd for C16H20F6N2O2S: C, 45.93;
11.66; N, 8.27; [
a
]
D
21 þ43.3 (c 2.95, CHCl3).
H, 4.82; N, 6.70. Found: C, 46.18; H, 4.73; N, 6.77; [
CHCl3).
a
]
D
22 ꢀ65.9 (c 1.28,
4.2.2. 4-Methyl-2-({[(1R,2R)-2-(piperidin-1-yl)cyclohexyl]imino}
methyl)phenol (8a). Yellow solid; mp 76e77 ꢁC; 1H NMR (CDCl3,
400 MHz)
d
1.20e1.48 (m, 9H), 1.54e1.67 (m, 1H), 1.69e1.95 (m,
4.2.7. 1-[3,5-Bis(trifluoromethyl)phenyl-3-[(1S,2S)-2-(piperidin-1-
yl)cyclohexyl]thiourea (11a). White solid; mp 79e81 ꢁC; 1H NMR
4H), 2.29 (s, 3H), 2.34e2.45 (m, 3H), 3.17 (dt, J¼10.4, 4.4 Hz, 1H),
6.86 (d, J¼8.5 Hz, 1H), 7.03 (d, J¼1.6 Hz, 1H), 7.09 (dd, J¼8.5, 2.2 Hz,
(CDCl3, 300 MHz)
2.27e2.40 (m, 3H), 2.53e2.65 (m, 3H), 3.68e3.82 (m, 1H), 7.70 (s,
1H), 7.84 (s, 2H); 13C NMR (CDCl3, 75 MHz)
23.4, 24.3, 24.5, 25.3,
26.3, 32.6, 49.6, 56.2, 68.9, 119.1, 122.9 (q, J¼273.4 Hz), 124.7, 132.8
d 1.07e1.42 (m, 10H), 1.68e1.96 (m, 3H),
1H), 8.16 (s, 1H), 13.75 (br s, 1H); 13C NMR (CDCl3, 75 MHz)
d 20.4,
24.6, 24.8, 25.0, 25.5, 26.7, 34.3, 50.0, 67.9, 67.9, 116.7, 118.4, 126.8,
d
130.8, 132.4, 159.5, 163.2; IR (KBr)
n 2931, 2850, 2792, 1626, 1589,
1494, 1445, 1282, 1157, 828, 774, 671, 575 cmꢀ1; MS (EI, 70 eV) m/z
300 ([Mþ], 35%), 217 (100%), 165 (30%), 150 (89%), 136 (26%), 124
(46%), 98 (29%), 84 (53%). Anal. Calcd for C19H28N2O: C, 75.96; H,
(q, J¼33.5 Hz), 139.8, 187.1; IR (KBr)
n 3249, 2935, 1533, 1471, 1381,
1274, 1172, 1128, 967, 884, 702, 680 cmꢀ1; MS (EI, 70 eV) m/z 453
([Mþ], 23%), 165 (100%), 124 (51%), 86 (52%). Anal. Calcd for
C20H25F62N13S: C, 52.97; H, 5.56; N, 9.27. Found: C, 52.99; H, 5.53; N,
9.39; N, 9.32. Found: C, 76.10; H, 9.43; N, 9.64; [
CHCl3).
a]
21 ꢀ157.7 (c 3.02,
D
9.09; [
a
]
D
þ13.4 (c 0.96, CHCl3).
4.2.3. 2-({[(1R,2R)-2-(Dimethylamino)cyclohexyl]imino}methyl)-4-
4.2.8. 1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1R,2R)-2-morpholino-
cyclohexyl]thiourea (11b). White solid; mp 176e177 ꢁC; 1H NMR
methylphenol (8b). Yellow oil; 1H NMR (CDCl3, 400 MHz)
d
1.20e1.39 (m, 3H), 1.52e1.68 (m, 1H), 1.68e1.92 (m, 4H), 2.26 (s,
(CDCl3, 400 MHz) d 1.05e1.42 (m, 4H), 1.69e1.99 (m, 3H), 2.30e2.41
6H), 2.28 (s, 3H), 2.50e2.62 (m, 1H), 3.20 (dt, J¼10.2, 4.2 Hz, 1H),
6.85 (d, J¼8.2 Hz, 1H), 7.02 (d, J¼2.2 Hz, 1H), 7.09 (dd, J¼8.4,
2.2 Hz, 1H), 8.24 (s, 1H), 13.55 (br s, 1H); 13C NMR (CDCl3,
(m, 3H), 2.61e2.74 (m, 3H), 3.47e3.60 (m, 4H), 3.95e4.07 (m, 1H),
6.71 (br s, 1H), 7.72 (s, 1H), 7.81 (s, 2H), 8.71 (br s, 1H); 13C NMR
(CDCl3, 75 MHz)
122.7 (q, J¼272.6 Hz), 123.6, 133.2 (q, J¼33.8 Hz), 138.9, 179.9; IR
(KBr) 3247, 2939, 1740, 1542, 1462, 1381, 1272, 1218, 1171, 1130,
1017, 971, 894, 849, 704, 681 cmꢀ1; MS (EI, 70 eV) m/z 455 ([Mþ],
d 23.3, 24.6, 25.3, 32.5, 48.5, 55.8, 67.4, 68.0, 119.1,
75 MHz)
118.7, 127.2, 131.1, 132.7, 159.4, 163.0; IR (capillary)
1493, 1278, 1157, 1033, 947, 819, 673 cmꢀ1; HRMS calcd for
d
20.2, 20.3, 23.9, 24.6, 25.2, 34.7, 40.8, 66.9, 69.3, 116.8,
n
2929, 1634,
n